KR100824212B1 - Composition for skin protection containing placenta and preparation method thereof - Google Patents

Composition for skin protection containing placenta and preparation method thereof Download PDF

Info

Publication number
KR100824212B1
KR100824212B1 KR1020060108563A KR20060108563A KR100824212B1 KR 100824212 B1 KR100824212 B1 KR 100824212B1 KR 1020060108563 A KR1020060108563 A KR 1020060108563A KR 20060108563 A KR20060108563 A KR 20060108563A KR 100824212 B1 KR100824212 B1 KR 100824212B1
Authority
KR
South Korea
Prior art keywords
placenta
skin
cream
composition
cleansing
Prior art date
Application number
KR1020060108563A
Other languages
Korean (ko)
Inventor
김윤범
Original Assignee
김윤범
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김윤범 filed Critical 김윤범
Priority to KR1020060108563A priority Critical patent/KR100824212B1/en
Application granted granted Critical
Publication of KR100824212B1 publication Critical patent/KR100824212B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982Reproductive organs; Embryos, Eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Abstract

A skin moisturizing cosmetic composition comprising placenta is provided to recover damaged skin barrier function and maintain the skin moisturizing power for a long time by stabilizing the placenta with an organogel, thereby protecting skin from various diseases such as atopic dermatitis and dry dermatitis and being effective for preventing skin aging. A skin moisturizing cosmetic composition comprises an aqueous solution of placenta encapsulated into a lecithin gel, wherein 0.0001-20 parts by weight of the placenta is used regarding 100 parts by weight of the total composition. A method for preparing the composition comprises the steps of: (a) after adjusting pH of the aqueous solution of the placenta into 3-4, filtering it to obtain filtrate; and (b) adding the filtrate to a solution comprising phosphatidylcholine and glycol with agitating to prepare the lecithin gel. Further, the composition is used as a form of face lotion, eye cream, massage cream, cleansing cream, cleansing foam, cleansing water, pack or essence.

Description

태반을 함유하는 피부보호용 조성물 및 그의 제조방법{Composition for skin protection containing placenta and preparation method thereof}Composition for skin protection containing placenta and preparation method thereof {Composition for skin protection containing placenta and preparation method}

본 발명은 태반(placenta)을 함유하는 피부보호용 조성물 및 그의 제조방법에 관한 것으로서, 보다 상세하게는, 태반을 오르가노겔(organogel) 내에 포집하여 안정화함으로써 우수한 손상된 피부장벽(barrier) 기능 회복, 피부 보습력 유지, 피부질환 예방 및 피부노화 방지 효과를 갖는 조성물 및 그의 제조방법에 관한 것이다.The present invention relates to a composition for protecting skin containing placenta and a method for manufacturing the same, and more particularly, to recover excellent damaged skin barrier function by collecting the placenta in an organogel and stabilizing the skin. The present invention relates to a composition having a moisturizing ability, to preventing skin diseases, and to preventing skin aging, and a method of manufacturing the same.

피부는 외부환경에 항상 노출되어 있으며, 신체를 보호하는 중요한 기관이다. 즉, 피부는 수분과 전해질의 소실을 억제하고, 정상적인 생화학적 대사 환경을 제공하며, 기계적인 자극과 자외선 및 각종 미생물로부터 인체를 보호하는 장벽 기능을 수행한다. 그러나 나이가 들어감에 따라, 피부는 자연 노화되기도 하고 자연환경에 의해, 특히 광노화에 의해 주름이 생기고 탄력이 저하되며, 거칠어지고 건조해지며 기미, 주근깨 등이 발생하여 미용 상 보기 좋지 않게 변하기도 할 뿐 아니라, 심하면 피부질환이 발생하기도 한다. 이러한 노화 현상이나 질병을 예방 하거나 개선하기 위하여, 비타민, 천연 추출물 등을 이용한 피부보호용 조성물에 대한 연구와 제품개발이 꾸준히 이루어지고 있다. 그러나 안전성과 안정성 측면에 있어서 만족할만한 연구 성과는 거두지 못하고 있는 실정이다.Skin is always exposed to the outside environment and is an important organ to protect the body. That is, the skin suppresses the loss of water and electrolytes, provides a normal biochemical metabolic environment, and performs a mechanical function and a barrier function to protect the human body from ultraviolet rays and various microorganisms. However, as you age, your skin may age naturally and wrinkles and elasticity may decrease due to the natural environment, especially photoaging, and it may become rough and dry, causing blemishes, freckles, etc. In addition, severe skin diseases may occur. In order to prevent or improve such aging phenomenon or disease, research and product development has been steadily made for the skin protection composition using vitamins, natural extracts and the like. However, satisfactory research results in terms of safety and stability have not been achieved.

최근에는 피부의 노화나 다양한 피부질환과 관련하여, 피부장벽의 기능이 중요한 역할을 한다고 밝혀져 피부장벽에 대한 관심이 높아지고 있다. 태반(자하거(紫河車))의 주요 성분은 필수 아마노산 외에 수십 종의 아미노산과 약리활성의 중심인 각종 활성 펩타이드 및 수백 종의 효소로 이루어져 있다. 동의보감을 비롯하여 현재까지 알려진 태반의 효능은 면역력 강화, 항산화, 항염증, 미백, 피부재생 효과 등이 있다(문헌 [Acta Pharmacol. Sin. 2003, 24(2), 187-92]). 특히, 한국특허 제24417호는 태반추출물과 코지산 또는 코지산 유도체를 함유하여 멜라닌 생성의 초기단계에 관여하는 티로시나아제를 억제함으로써 피부미백 효과를 나타내는 화장료 조성물을 개시한 바 있다. 그러나 지금까지 태반을 이용한 노화 예방용 피부보호 조성물에 대한 연구는 알려진 바가 없었다.Recently, it has been found that the function of the skin barrier plays an important role in relation to aging of the skin and various skin diseases, and interest in the skin barrier is increasing. The main component of the placenta (Zhahager) consists of dozens of amino acids and various active peptides and hundreds of enzymes that are central to pharmacological activity in addition to the essential amino acid. The efficacy of the placenta, known to the extent of consent, has been shown to enhance immunity, antioxidant, anti-inflammatory, whitening, and skin regeneration (Acta Pharmacol. Sin. 2003, 24 (2), 187-92). In particular, Korean Patent No. 24417 discloses a cosmetic composition exhibiting a skin whitening effect by containing a placental extract and kojic acid or kojic acid derivatives to inhibit tyrosinase involved in the initial stage of melanogenesis. However, until now, the research on the skin protection composition for preventing aging using the placenta has not been known.

한편, "오르가노겔" 이라는 용어는 젤라틴 용액과 함께, 유-중-수(water-in-oil) 역 마이크로에멀젼의 겔화의 특이적 개념을 설명하기 위해 처음 사용되었다(문헌 [Luisi et al., Colloid & Polymer Science, 1990, vol. 268, pp. 356-374]). 이 용어는 최근 포스파티딜콜린(phosphatidylcholine)이 풍부한 레시틴(lecithin)으로 안정화되는 2가지 불혼화성 상들(유-중-수)을 함유하는 겔화된 계, 주로 수소화된 계에까지 확장되었다(문헌 ([Williman et al., Journal of Pharmaceutical Sciences, 1992, vol. 81, pp. 871- 874] 및 [Schchipunov et al., Colloid Journal, 1995, vol. 57, pp. 556-560])). 이 에멀젼은 라멜라상을 가지고, 겔화제의 부재 시에도 겔 형태이므로, 오르가노겔이라는 이름은 W/O 또는 O/W이든 유화액의 의미와 상관없이 그러한 형태의 에멀젼을 나타낸다. 그 후, 물이 폴리올로 대체되면서, 글리콜/오일 에멀젼을 형성하고, 수소첨가된 레시틴으로 안정화되는, 유사한 에멀젼들이 개발되어 왔다. 높은 함량의 폴리올을 함유하는 상기 형태의 에멀젼은 피부 상의 에멀젼에 의해 형성된 막에 의해 상피투과 수분 손실(즉, TEWL)을 감소시키고, 피부 보습을 허용하면서, 흡습성이 높은 다량의 폴리올을 공급함으로써, 피부의 우수한 보습효과 부여에 특히 유리하다. 그러나 지금까지 태반을 오르가노겔 내에 포집하여 안정화한 기술은 전혀 알려진 바 없었다.On the other hand, the term "organogel" was first used to describe the specific concept of gelation of water-in-oil inverse microemulsions with gelatin solutions (Luisi et al. , Colloid & Polymer Science, 1990, vol. 268, pp. 356-374]. The term has recently been extended to gelled systems, mainly hydrogenated systems, containing two immiscible phases (oil-in-water) stabilized with lecithin enriched with phosphatidylcholine (Williman et al. ., Journal of Pharmaceutical Sciences, 1992, vol. 81, pp. 871- 874 and Schchipunov et al., Colloid Journal, 1995, vol. 57, pp. 556-560)). Since this emulsion has a lamellar phase and is in the form of a gel even in the absence of a gelling agent, the name organogel denotes an emulsion of that form regardless of the meaning of the emulsion, whether W / O or O / W. Subsequently, similar emulsions have been developed, in which water is replaced with polyols, which form glycol / oil emulsions and stabilize with hydrogenated lecithin. Emulsions of this type containing high amounts of polyols reduce the epithelial moisture loss (i.e., TEWL) by the membrane formed by the emulsion on the skin, and by supplying a large amount of hygroscopic polyols while allowing skin moisturization, It is particularly advantageous for imparting excellent moisturizing effect to the skin. However, until now, no technique has been known to capture and stabilize the placenta in organogel.

본 발명자들은 손상된 피부장벽의 기능 회복에 대한 연구를 진행해오던 중 태반이 우수한 효과를 가짐을 발견하였다. 나아가, 본 발명자들은 태반을 물에 용해시키고 유기산으로 처리한 용액을 오르가노겔 구조로 감쌈으로써 피부 적용 시 효능을 극대화하고, 사용하기 편리한 피부보호용 조성물을 제조할 수 있음을 발견하고, 본 발명을 완성하기에 이르렀다.The present inventors have found that the placenta has an excellent effect during the study on the restoration of function of the damaged skin barrier. Furthermore, the present inventors found that dissolving the placenta in water and wrapping the solution treated with organic acid in an organogel structure maximizes the efficacy when applying the skin and can prepare a convenient skin care composition. It was completed.

따라서 본 발명의 목적은 오르가노겔 내에 포집된 태반을 이용하여 손상된 피부장벽의 기능을 회복하고 피부를 각종 질병으로부터 보호하며 피부노화를 방지할 수 있는 피부보호용 화장료 조성물을 제공하기 위한 것이다.Accordingly, an object of the present invention is to provide a skin protection cosmetic composition that can restore the function of the damaged skin barrier using the placenta collected in the organogel, protect the skin from various diseases, and prevent skin aging.

본 발명의 다른 목적은 상기 조성물의 제조방법을 제공하기 위한 것이다.Another object of the present invention is to provide a method for preparing the composition.

첫째, 본 발명은 오르가노겔 내에 포집된 태반을 함유하는, 피부보호용 화장료 조성물에 관한 것이다. 본 발명의 조성물에 있어서, 오르가노겔은 레시틴겔인 것이 바람직하고, 전체 화장료 조성물 100 중량부에 대하여 태반을 0.0001~20 중량부로 함유하는 것이 바람직하다. 본 발명의 조성물은 유연화장수, 수렴화장수, 영양화장수, 아이크림, 영양크림, 맛사지크림, 클렌징 크림, 클렌징 폼, 클렌징 워터, 팩 또는 엣센스의 형태로 제조될 수 있다.First, the present invention relates to a cosmetic composition for skin protection, containing the placenta collected in the organogel. In the composition of the present invention, the organogel is preferably lecithin gel, and it is preferable to contain the placenta at 0.0001 to 20 parts by weight based on 100 parts by weight of the total cosmetic composition. The composition of the present invention may be prepared in the form of softening cream, astringent makeup, nourishing cream, eye cream, nutrition cream, massage cream, cleansing cream, cleansing foam, cleansing water, pack or essence.

둘째, 본 발명은Second, the present invention

1) 태반 수용액에 유기산을 가하여 pH를 3~4로 조정한 후 여과하여 여액을 얻고;1) adding an organic acid to the placental aqueous solution to adjust the pH to 3-4, and then filtrate to obtain a filtrate;

2) 단계 1)의 여액을 유기용매 중에 오일 및 글리콜을 함유하는 용액에 가하고 교반하여 오르가노겔을 제조하는:2) adding the filtrate of step 1) to a solution containing oil and glycol in an organic solvent and stirring to prepare an organogel:

단계를 포함하는, 상기 조성물의 제조방법에 관한 것이다. 본 발명에 따른 방법에 있어서, 오일은 포스파티딜콜린을 함유하는 것, 특히 포스파티딜콜린과 중쇄 지방산 트리글리세라이드(medium chain triglyceride)로 이루어지는 것일 수 있고, 글리콜은 프로필렌글리콜일 수 있으며, 유기용매는 에탄올일 수 있다.It relates to a method of preparing the composition, comprising the step. In the process according to the invention, the oil may be one containing phosphatidylcholine, in particular phosphatidylcholine and medium chain triglycerides, the glycol may be propylene glycol, and the organic solvent may be ethanol.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명에서, 태반은 상업적으로 입수가능한 제품으로서, 예를 들어, 수용액으로 제조한 후 유기산, 예를 들어 젖산(lactic acid)을 가하여 pH를 3~4 범위로 조절하여 여과한 여액을 사용할 수 있다.In the present invention, the placenta is a commercially available product, for example, prepared in an aqueous solution, and then filtered using an organic acid, for example lactic acid, by adjusting the pH to a range of 3-4. .

오르가노겔은 W/O(water-in-oil) 마이크로에멀젼 계로 이루어져 수용성 물질을 겔 내에서 안정화할 수 있는 최적의 시스템으로서, 대표적으로 젤라틴겔과 레시틴겔을 들 수 있다. 본 발명에서는, 특히 레시틴겔을 사용할 수 있으며, 태반을 물에 녹여 유기산을 가하여 제조된 태반 수용액을 레시틴겔 내에 포집하여 그 효과를 극대화할 수 있다. 레시틴겔은 산물 내에 결합수의 양을 증대시키는 피부유사 구조를 갖고 있어, 피부 도포 시 피부에 수분을 장시간 지속적으로 공급하고, 수분의 손실을 막아주는 강력한 보습효과를 갖는다.Organogel is composed of a water-in-oil (W / O) microemulsion system and is an optimal system for stabilizing a water-soluble substance in a gel. Representative examples thereof include gelatin gel and lecithin gel. In the present invention, in particular, lecithin gel can be used, and the placenta aqueous solution prepared by dissolving the placenta in water and adding an organic acid can be collected in the lecithin gel to maximize its effect. Lecithin gel has a skin-like structure that increases the amount of bound water in the product, has a strong moisturizing effect to continuously supply moisture to the skin for a long time when applying the skin, and to prevent the loss of moisture.

본 발명의 조성물에서 태반의 함량은 전체 화장료 조성물 100 중량부에 대하여 0.0001~20 중량부인 것이 바람직하며, 0.001~10 중량부인 것이 보다 바람직하며, 0.01~10 중량부인 것이 가장 바람직하다. 이는 상기 함량 범위 내에서 목적하는 효과를 극대화할 수 있기 때문이다.The content of the placenta in the composition of the present invention is preferably 0.0001 to 20 parts by weight, more preferably 0.001 to 10 parts by weight, and most preferably 0.01 to 10 parts by weight based on 100 parts by weight of the total cosmetic composition. This is because it is possible to maximize the desired effect within the content range.

상기 본 발명의 조성물은The composition of the present invention

1) 태반 수용액에 유기산, 예를 들어 젖산을 가하여 pH를 3~4로 조정한 후 여과하여 여액을 얻고;1) adding an organic acid, for example lactic acid, to the placental aqueous solution to adjust the pH to 3-4, followed by filtration to obtain a filtrate;

2) 단계 1)의 여액을 유기용매, 예를 들어 에탄올 중에 오일, 예를 들어 포스파티딜콜린 및 중쇄 지방산 트리글리세리드, 및 글리콜, 예를 들어 프로필렌글리콜을 함유하는 용액에 가하고 교반하여 오르가노겔을 제조하는:2) The filtrate of step 1) is added to a solution containing oils such as phosphatidylcholine and medium chain fatty acid triglycerides, and glycols such as propylene glycol in an organic solvent such as ethanol and stirred to prepare an organogel:

단계를 포함하는 방법에 의해 제조될 수 있다.It may be prepared by a method comprising the step.

본 발명의 조성물은 당업계에 통상적인 어떠한 제형으로도 제조될 수 있으며, 예를 들어 용액, 현탁액, 유탁액, 페이스트, 연고, 겔, 크림, 로션, 파우더, 비누 등으로 제형화될 수 있으나, 이들로 한정되는 것은 아니다. 또한, 본 발명의 조성물은 유연화장수, 수렴화장수, 영양화장수, 아이크림, 영양크림, 맛사지크림, 클렌징 크림, 클렌징 폼, 클렌징 워터, 팩 또는 엣센스의 형태로 제조될 수 있으나, 이들로 한정되는 것은 아니다.The compositions of the present invention may be prepared in any formulation conventional in the art, and may, for example, be formulated in solutions, suspensions, emulsions, pastes, ointments, gels, creams, lotions, powders, soaps, and the like. It is not limited to these. In addition, the composition of the present invention may be prepared in the form of softening cream, astringent makeup, nutrition cream, eye cream, nutrition cream, massage cream, cleansing cream, cleansing foam, cleansing water, pack or essence, but is not limited thereto no.

본 발명에 따른 조성물은 손상된 피부장벽 기능을 회복하는 태반을 함유하기 때문에 피부 보습력을 크게 향상시킬 수 있으며, 이와 같은 효과는 아토피 피부염이나 건성 피부염의 예방 및 치료에 효과적이다.Since the composition according to the present invention contains the placenta that restores impaired skin barrier function, the skin moisturizing ability can be greatly improved, and this effect is effective for the prevention and treatment of atopic dermatitis or dry dermatitis.

이하, 본 발명을 실시예에 의해 보다 구체적으로 설명하나, 이는 본 발명의 이해를 돕기 위한 것일 뿐 본 발명의 범위를 어떤 식으로든 제한하고자 하는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples, which are intended to aid the understanding of the present invention but are not intended to limit the scope of the present invention in any way.

제조예: 태반 수용액의 제조Preparation Example: Preparation of Placental Aqueous Solution

태반 2 g을 물 10 ㎖에 가한 후 젖산을 이용하여 pH 3~4로 조정하였다. 상기 수용액을 10 분 동안 교반하고 여과지를 통해 여액을 모았다.2 g of placenta were added to 10 ml of water, and then adjusted to pH 3-4 using lactic acid. The aqueous solution was stirred for 10 minutes and the filtrate was collected through filter paper.

실시예: 태반을 함유하는 레시틴겔의 제조Example Preparation of Lecithin Gel Containing Placenta

포스파티딜콜린(Lipoid S100-3) 6 g, 에탄올 10 g, MCT(Medium Chain Triglyceride) 10 g 및 프로필렌글리콜 54.0 g이 용해된 용액에 상기 제조예에서 제조된 태반 수용액 20 g을 첨가하고 실온에서 교반하여 레시틴겔을 제조하였다.To a solution in which 6 g of phosphatidylcholine (Lipoid S100-3), 10 g of ethanol, 10 g of medium chain triglyceride (MCT), and 54.0 g of propylene glycol were added, 20 g of the placental aqueous solution prepared in Preparation Example was added and stirred at room temperature to make lecithin. Gels were prepared.

제제예: 레시틴겔을 함유하는 크림제의 제조Formulation Example: Preparation of Cream Containing Lecithin Gel

성 분ingredient 함 량(중량%)Content (% by weight) 실시예의 레시틴겔Example Lecithin Gel 20.020.0 동백유Camellia oil 3.0 3.0 스테아릴알콜Stearyl alcohol 1.5 1.5 스테아르산Stearic acid 1.5 1.5 글리세릴스테아레이트Glyceryl Stearate 1.5 1.5 유동파라핀Liquid paraffin 10.010.0 밀납Beeswax 2.0 2.0 폴리솔베이트Polysorbate 2.5 2.5 솔비탄Sorbitan 0.5 0.5 스쿠알란Squalane 3.0 3.0 1,3-BG(1,3-butylene glycol)1,3-BG (1,3-butylene glycol) 3.0 3.0 글리세린glycerin 5.0 5.0 트리에탄올 아민Triethanol amine 0.5 0.5 토코페릴아세테이트Tocopheryl Acetate 0.5 0.5 산뽕(山桑) 추출물Mountain Mulberry Extract 2.0 2.0 방부제antiseptic 적량Quantity 색소Pigment 적량Quantity 향료Spices 적량Quantity 정제수Purified water 100까지Up to 100

상기 표 1에 나타낸 성분 및 함량으로 통상적인 방법에 따라 크림제를 제조하였다.A cream was prepared according to a conventional method with the ingredients and contents shown in Table 1 above.

비교 제제예: 레시틴겔을 함유하지 않는 크림제의 제조Comparative Formulation Example: Preparation of Cream without Lecithin Gel

상기 표 1에서 레시틴겔을 제외한 성분 및 함량으로 상기 제제예 1과 실질적으로 동일한 방법에 따라 크림제를 제조하였다.In Table 1, except for the lecithin gel, a cream was prepared in substantially the same manner as in Formulation Example 1 and the content.

실험예 1: 보습효과 평가Experimental Example 1: Evaluation of moisturizing effect

상기 제제예와 비교 제제예에 따라 제조된 조성물에 대하여 다음과 같이 보습력을 평가하였다.The moisturizing power of the composition prepared according to the above formulation example and the comparative formulation example was evaluated as follows.

1) 수분 보유능 시험 1) water-holding ability test

온도 25 ℃ 및 상대습도 45%의 항온항습실에서 제제예 및 비교 제제예에서 얻은 크림제를 각각 30명의 피시험자 하박 안쪽에 0.03 g/16 ㎠의 양으로 도포한 후 잘 문지르고 나서, 도포 전과 도포 1 시간 및 2 시간 후에 피부의 수분 함량(보습력)을 측정하였다. 측정기기로는 피부의 수분 함량에 따른 피부의 전기용량을 측정하여 보습력을 측정하는 피부수분 함량 측정기(corneometer CM820, Khazaka사)를 사용하였다.In a constant temperature and humidity room with a temperature of 25 ° C. and a relative humidity of 45%, the creams obtained in Formulation Examples and Comparative Formulation Examples were respectively applied in an amount of 0.03 g / 16 cm 2 to the inner half of 30 test subjects, followed by rubbing well, and before and after application. After 1 hour and 2 hours the moisture content (moisturizing) of the skin was measured. As a measuring device, a skin moisture content measuring instrument (corneometer CM820, Khazaka Co., Ltd.) was used to measure the moisturizing power by measuring the electric capacitance of the skin according to the moisture content of the skin.

전기 전도도Electrical conductivity 제제예Formulation example 비교 제제예Comparative Formulation Example 도포 전Before application 50 50 5050 도포 1 시간 후1 hour after application 111111 7676 도포 2 시간 후2 hours after application 96 96 6565

상기 표 2에 나타낸 바와 같이, 본 발명의 레시틴겔을 함유하는 조성물은 레시틴겔을 함유하지 않는 조성물과 비교하여 현저하게 증가된(약 1.5배) 보습 효과를 나타내는 것으로 확인되었다.As shown in Table 2, the composition containing the lecithin gel of the present invention was found to exhibit a significantly increased (about 1.5 times) moisturizing effect compared to the composition containing no lecithin gel.

2) 수분 증발량 시험 2) Moisture evaporation test

팔의 상박 부위에 테이프 스트리핑(tape stripping)을 실시하여 피부의 방어막을 약화시킨 후, 온도 25 ℃ 및 상대습도 40%의 항온항습실에서 제제예 및 비교 제제예에서 얻은 크림제를 각각 20명의 피시험자 상박 안쪽에 0.03 g/16 ㎠의 양으로 도포한 후 잘 문지르고 나서, 수분 증발량 측정기(TEWL meter, KOLN사)를 이용하여 8 시간마다 1 분 간격으로 5회 측정하여 이의 평균값을 구하였다.After tape stripping on the upper arm of the arm to weaken the skin's protective film, the creams obtained in Formulation Example and Comparative Formulation Example were prepared in 20 constant temperature and humidity chambers with a temperature of 25 ° C. and a relative humidity of 40%. After coating in an amount of 0.03 g / 16 cm 2 inside the upper arm and rubbed well, using a water evaporation meter (TEWL meter, KOLN Co., Ltd.) was measured 5 times at 1 minute intervals every 8 hours to obtain an average value thereof.

처치 후 시간(시간)Post kill time (hours) 제제예(%)Formulation example (%) 비교 제제예(%)Comparative formulation example (%) 0 0 4.1  4.1 4.1 4.1 8 8 -10.5-10.5 -5.5-5.5 1616 -8.8 -8.8 -1.7-1.7 2424 -6.7 -6.7 4.1 4.1 3232 -4.5 -4.5 5.3 5.3

상기 표 3에 나타낸 바와 같이, 본 발명의 레시틴겔을 함유하는 조성물은 레시틴겔을 함유하지 않는 조성물과 비교하여 현저하게 증가된 수분 증발 억제효과를 갖는 것으로 나타났다.As shown in Table 3, the composition containing the lecithin gel of the present invention was shown to have a significantly increased water evaporation inhibiting effect compared to the composition containing no lecithin gel.

실험예 2: 각질 박리효과 측정Experimental Example 2: Measurement of the exfoliation effect

본 발명에 따른 조성물의 각질 박리효과를 측정하기 위하여 다음과 같은 실험을 수행하였다.In order to measure the exfoliation effect of the composition according to the present invention, the following experiment was performed.

10% 디히드록시아세톤(DHA; dihydroxy acetone) 용액 0.4 ㎖를 힐탑 챔버에 넣고 20명의 시험자의 상박 안쪽에 1 시간 동안 부착한 후 제거하였다. 착색의 정도를 높이기 위하여 6 시간이 경과한 후 DHA 용액으로 다시 한 번 처리하여 착색 시켰다. 20명을 무작위로 A 및 B의 두 그룹으로 나누었다. A 그룹에는 레시틴겔을 함유하는 제제예의 크림제를, B 그룹에는 레시틴겔을 함유하지 않는 비교 제제예의 크림제를 각각 1 일 2회씩 2 주간 도포한 후, 피부색의 변화를 크로마미터(chromameter)(Minolta CR300)를 이용하여 색의 밝기변화(ΔL)를 측정함으로써 평가하였다. 또한, 복수의 숙련자에 의한 객관적 육안 관찰과 피검자에 의한 주관적 육안 관찰을 실시하여 하기 등급의 분류에 따라 미백효과를 측정하였다: -3: 매우악화, -2: 악화, -1: 약간 악화, 0: 변화 없음, 1: 약간 개선, 2: 개선, 3: 매우 개선. 그 결과를 표 4에 나타내었다.0.4 ml of a 10% dihydroxy acetone (DHA) solution was placed in a hilltop chamber and attached to the inside of the upper arm of 20 testers for 1 hour and then removed. In order to increase the degree of coloration, after 6 hours, the resultant was treated with DHA solution and colored again. Twenty people were randomly divided into two groups, A and B. Group A was applied a cream agent of the formulation example containing lecithin gel, and group B a cream agent of the comparative formulation example containing no lecithin gel was applied twice a day for 2 weeks, and then the change of the skin color was measured by a chromatometer ( Minolta CR300) was used to measure the change in brightness of color (ΔL). In addition, objective visual observation by a plurality of skilled workers and subjective visual observation by a subject were carried out, and the whitening effect was measured according to the following classification: -3: very worse, -2: worse, -1: slightly worse, 0 : No change, 1: slightly improved, 2: improved, 3: highly improved. The results are shown in Table 4.

피부색 밝기변화(ΔL)Skin color change (ΔL) 숙련자의 객관적 평가Objective evaluation of the skilled person 피검자의 주관적 평가Subjective Evaluation of the Subject 피검자Subject AA BB AA BB AA BB 1 One 7.27.2 4.94.9 33 1One 33 22 2 2 6.96.9 5.15.1 33 22 22 33 3 3 7.77.7 4.84.8 33 33 33 33 4 4 7.37.3 4.14.1 22 22 22 1One 5 5 8.08.0 4.94.9 33 22 33 1One 6 6 7.57.5 5.45.4 33 22 22 1One 7 7 8.88.8 5.25.2 33 1One 33 00 8 8 6.76.7 4.84.8 33 33 33 22 9 9 7.47.4 5.95.9 33 22 33 33 1010 8.78.7 5.65.6 22 1One 33 33 평균Average 7.627.62 5.075.07 2.92.9 1.91.9 2.72.7 2.02.0

상기 표 4에 나타낸 바와 같이, 본 발명의 레시틴겔을 함유하는 크림제를 도포한 A 그룹은 레시틴겔을 함유하지 않는 크림제를 도포한 B 그룹에 비해 3가지 평가에서 모두 우수한 각질 박리효과를 갖는 것으로 확인되었다.As shown in Table 4, the group A coated with the lecithin gel-containing cream of the present invention has excellent keratin exfoliation effect in all three evaluations compared to the group B coated with the cream containing no lecithin gel. It was confirmed that.

본 발명에 따르면, 태반을 오르가노겔로서 안정화함으로써 손상된 피부장벽 기능을 회복하고 피부 보습력을 장시간 유지할 수 있어 피부를 아토피 피부염, 건성 피부염 등을 비롯한 각종 질병으로부터 보호할 수 있을 뿐 아니라 피부노화 방지에 효과적인 조성물을 제공할 수 있다.According to the present invention, by stabilizing the placenta as an organogel can restore the damaged skin barrier function and maintain the skin moisturizing power for a long time can not only protect the skin from various diseases, including atopic dermatitis, dry dermatitis, but also to prevent skin aging Effective compositions can be provided.

Claims (7)

삭제delete 레시틴겔 내에 포집된 태반 수용액을 함유하는, 피부보습용 화장료 조성물.A cosmetic composition for moisturizing skin containing an aqueous solution of placenta collected in lecithin gel. 제2항에 있어서, 전체 화장료 조성물 100 중량부에 대하여 태반이 0.0001~20 중량부로 사용된 것인 조성물.The composition of claim 2, wherein the placenta is used in an amount of 0.0001 to 20 parts by weight based on 100 parts by weight of the total cosmetic composition. 제2항에 있어서, 유연화장수, 수렴화장수, 영양화장수, 아이크림, 영양크림, 맛사지크림, 클렌징 크림, 클렌징 폼, 클렌징 워터, 팩 또는 엣센스의 형태로 제조되는 조성물.The composition according to claim 2, which is prepared in the form of softening cream, converging cream, nourishing cream, eye cream, nourishing cream, massage cream, cleansing cream, cleansing foam, cleansing water, pack or essence. 삭제delete 1) 태반 수용액의 pH를 3~4로 조정한 후 여과하여 여액을 얻고;1) the pH of the placental aqueous solution was adjusted to 3-4, followed by filtration to obtain a filtrate; 2) 단계 1)의 여액을 포스파티딜콜린과 글리콜을 함유하는 용액에 가하여 교반하여 레시틴겔을 제조하는:2) adding the filtrate of step 1) to a solution containing phosphatidylcholine and glycol and stirring to prepare a lecithin gel: 단계를 포함하는, 제2항 내지 제4항 중 어느 한 항에 따른 조성물의 제조방법.Method for producing a composition according to any one of claims 2 to 4, comprising the step. 제6항에 있어서, 상기 용액이 중쇄 지방산 트리글리세라이드를 추가로 포함하고, 글리콜이 프로필렌글리콜인 방법.The method of claim 6, wherein the solution further comprises a medium chain fatty acid triglyceride and the glycol is propylene glycol.
KR1020060108563A 2006-11-03 2006-11-03 Composition for skin protection containing placenta and preparation method thereof KR100824212B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060108563A KR100824212B1 (en) 2006-11-03 2006-11-03 Composition for skin protection containing placenta and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060108563A KR100824212B1 (en) 2006-11-03 2006-11-03 Composition for skin protection containing placenta and preparation method thereof

Publications (1)

Publication Number Publication Date
KR100824212B1 true KR100824212B1 (en) 2008-04-24

Family

ID=39572210

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060108563A KR100824212B1 (en) 2006-11-03 2006-11-03 Composition for skin protection containing placenta and preparation method thereof

Country Status (1)

Country Link
KR (1) KR100824212B1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101140573B1 (en) * 2009-06-24 2012-05-02 농업회사법인 제주마산업 주식회사 External Skin Preparation Using an Extract of Horse Plancenta
KR101299658B1 (en) * 2010-09-28 2013-08-26 바이오스펙트럼 주식회사 Composition for Promoting Stem Cell Proliferation Comprising Equidae Placenta extracts
WO2013157891A1 (en) * 2012-04-19 2013-10-24 부산대학교 산학협력단 Topical pharmaceutical composition for preventing or treating skin side effects caused by egfr inhibitor
CN105496894A (en) * 2015-12-29 2016-04-20 李建会 Composition for nursing eye skin
WO2019098468A1 (en) * 2017-11-15 2019-05-23 주식회사 프롬바이오 Food or cosmetic composition for skin whitening, skin moisturizing, or skin wrinkle improvement, comprising composite of sheep placenta powder and plants
KR20200092709A (en) * 2019-01-25 2020-08-04 제주대학교 산학협력단 Pluronic Lecithin Organogel composition with improved storage stability at low temperature
WO2022198771A1 (en) * 2021-03-26 2022-09-29 广州赛莱拉生物基因工程有限公司 Composition containing animal placental exosomes, preparation method therefor and use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH111423A (en) * 1997-06-10 1999-01-06 Sunstar Inc Skin beautifying cosmetic

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH111423A (en) * 1997-06-10 1999-01-06 Sunstar Inc Skin beautifying cosmetic

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101140573B1 (en) * 2009-06-24 2012-05-02 농업회사법인 제주마산업 주식회사 External Skin Preparation Using an Extract of Horse Plancenta
KR101299658B1 (en) * 2010-09-28 2013-08-26 바이오스펙트럼 주식회사 Composition for Promoting Stem Cell Proliferation Comprising Equidae Placenta extracts
WO2013157891A1 (en) * 2012-04-19 2013-10-24 부산대학교 산학협력단 Topical pharmaceutical composition for preventing or treating skin side effects caused by egfr inhibitor
CN105496894A (en) * 2015-12-29 2016-04-20 李建会 Composition for nursing eye skin
WO2019098468A1 (en) * 2017-11-15 2019-05-23 주식회사 프롬바이오 Food or cosmetic composition for skin whitening, skin moisturizing, or skin wrinkle improvement, comprising composite of sheep placenta powder and plants
KR20200092709A (en) * 2019-01-25 2020-08-04 제주대학교 산학협력단 Pluronic Lecithin Organogel composition with improved storage stability at low temperature
KR102184802B1 (en) 2019-01-25 2020-12-01 제주대학교 산학협력단 Pluronic Lecithin Organogel composition with improved storage stability at low temperature
WO2022198771A1 (en) * 2021-03-26 2022-09-29 广州赛莱拉生物基因工程有限公司 Composition containing animal placental exosomes, preparation method therefor and use thereof

Similar Documents

Publication Publication Date Title
CN108904302A (en) A kind of fullerene topical composition
KR100824212B1 (en) Composition for skin protection containing placenta and preparation method thereof
KR102227355B1 (en) Complex cosmetic composition for non-irritating weak acid exfoliation and epithelial cell nutrition
KR102236253B1 (en) Cosmetic composition for skin improvement comprising extracts derived from natural products and method for manufacturing the same
KR102142311B1 (en) Skin external composition comprising tangeretin
JP2001163794A (en) Promoter for production of hyaluronic acid and preparation for external use for skin
KR102220743B1 (en) Cosmetic composition comprising totarol and mask pack using the same
KR20050103903A (en) Topical composition and methods for treatment of aged or environmentally damaged skin
KR102006712B1 (en) Cosmetic Compositions Containing Extract of Deer Antler
KR20120000251A (en) A cosmetic composition comprising laminaria japonica
KR20090009054A (en) Cosmetic composition comprising nanovesicle vitatox which having the effect of anti-oxidation and the effect of anti- wrinkle around the eye
KR20190068363A (en) Cosmetic composition for skin Humectant comprising Opuntia Ficus-Indica fruit extract and mixed compound of panthenol, hyaluronic acid and betaine
KR100638053B1 (en) Cosmetic composition for abirritating skin containing extract of rumex crispus as active ingredient
KR101440844B1 (en) Cosmetic composition with Linum usitatissimum seed mucus or the extract of Linum usitatissimum seed mucus
KR20120009147A (en) Composition of skin external application for moisturizing the skin containing Oldenlandia diffusa extracts
KR20110051880A (en) Cosmetic composition for moisturizing and firming the skin
JP3522609B2 (en) Hyaluronic acid production promoter and skin external preparation containing the same
JP2004067552A (en) Collagen production promoter, and cosmetic containing the same
KR101648466B1 (en) Cosmetic composition for improving skin
KR20080108065A (en) Manufacturing method of cometic compositions containing extract of paeonia suffruticosa andrew
KR101009767B1 (en) Cosmetic Composition for Desquamation Containing a Papain and the Extract of Nopal
KR20070008270A (en) Cosmetic composition for preventing skin aging comprising radix glycyrrhizae, phellodendri cortex, radix cynanchi wilfordii and cortex mori extract stabilized in nanoliposome
JP4630102B2 (en) Hyaluronic acid production promoter and cosmetics containing the same
JP2000226311A (en) Anti-aging agent
KR101825599B1 (en) Composition of skin external application for moisturizing the skin containing Oldenlandia diffusa extracts

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee